Recent

% | $
Quotes you view appear here for quick access.

ArQule Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • pharmainvestor11 pharmainvestor11 May 16, 2012 8:02 PM Flag

    ASSO Abstracts Info Out Tonight

    2nd-line HCC is a new indication for me. However,

    "benefits were obtained in Met+ pts, with preliminary OS trend favoring T (HR=0.47) and no detrimental effect in Met- pts"

    HR and p-values are very solid,

    PS
    I wish to see the same results in the NSCLC trial.

    What is OS for 2nd-line HCC patients?

 
ARQL
1.48+0.03(+2.07%)Aug 30 4:00 PMEDT